Lifecore Biomedical Inc
NASDAQ:LFCR
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
5.1
8.78
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| US |
|
Lifecore Biomedical Inc
NASDAQ:LFCR
|
308m USD |
Loading...
|
|
| JP |
G
|
Goyo Foods Industry Co Ltd
TSE:2230
|
53.2T JPY |
Loading...
|
|
| CH |
|
Nestle SA
SIX:NESN
|
190.3B CHF |
Loading...
|
|
| US |
|
Mondelez International Inc
NASDAQ:MDLZ
|
73.9B USD |
Loading...
|
|
| FR |
|
Danone SA
PAR:BN
|
48.5B EUR |
Loading...
|
|
| ZA |
T
|
Tiger Brands Ltd
JSE:TBS
|
53.6B Zac |
Loading...
|
|
| MY |
O
|
Ocb Bhd
KLSE:OCB
|
204B MYR |
Loading...
|
|
| US |
|
Hershey Co
NYSE:HSY
|
40.1B USD |
Loading...
|
|
| CN |
|
Muyuan Foods Co Ltd
SZSE:002714
|
258.6B CNY |
Loading...
|
|
| ZA |
A
|
Avi Ltd
JSE:AVI
|
36.4B Zac |
Loading...
|
|
| CH |
|
Chocoladefabriken Lindt & Spruengli AG
SIX:LISN
|
26.4B CHF |
Loading...
|
Market Distribution
| Min | -3 291 400% |
| 30th Percentile | 1.3% |
| Median | 8.6% |
| 70th Percentile | 16.8% |
| Max | 1 032 600% |
Other Profitability Ratios
Lifecore Biomedical Inc
Glance View
Lifecore Biomedical, Inc. engages in the design, development, manufacture, and sale of health and wellness products for food and biomaterials markets. The company is headquartered in Chaska, Minnesota and currently employs 689 full-time employees. The firm offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials, as well as the manufacture of pharmaceutical-grade Hyaluronic Acid. The company provides complete CDMO services for injectable pharmaceuticals and medical devices. The Company’s services include sodium hyaluronate, development, manufacturing, and analytical services. The company offers a range of average molecular weights and custom modifications for research and development (R&D), clinical, and commercial applications. The Company’s therapeutic applications include drug delivery, biomaterials, ophthalmology, orthopedics, aesthetics, oncology, and pain management. Its development capabilities include formulation, sterile filtration, filling, packaging, testing, and secondary sterilization.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Lifecore Biomedical Inc is -1.8%, which is above its 3-year median of -11.5%.
Over the last 3 years, Lifecore Biomedical Inc’s Operating Margin has increased from -17.7% to -1.8%. During this period, it reached a low of -25.7% on Aug 27, 2023 and a high of -1.8% on Oct 30, 2025.